Mr. Darren Novak is a Managing Director at J.P. Morgan’s Mergers & Acquisitions Group and heads the EMEA Shareholder Engagement and M&A Capital Markets practice.
Prior to joining J.P. Morgan, Darren was a member of the Mergers & Acquisitions Group of UBS Investment Bank where he lead UBS’s activist defence efforts globally. Prior to joining UBS Investment Bank, Darren co-led the Activist Situations Team at Houlihan Lokey. He has advised in many of the leading situations since 2010, including campaigns with respect to Bayer, BHP, CRH, CSX, Darden, Kirin, MetroPCS and NXP. Prior to Houlihan Lokey, Darren was an M&A attorney for a dozen years, most recently as a partner at Davies Ward specialising in contested situations, and before that as a Senior Associate in the M&A department of Simpson Thacher.
Darren received a JD and MBA from the University of Toronto. He graduated with distinction with a Bachelor of Commerce (Finance) from the University of Alberta.
Wednesday December 7, 2022
Regulatory and Market Drivers and Consequent Expectations for SPACs in Europe
- What does the tumultuous market for SPACs in the U.S. say about where things are heading in Europe?
- What trends will cross the Atlantic? What are the differences?
- What should we expect for Europe-listed SPACs and How Do We Avoid the Downside?